P. Bart Duell, M.D, is senior author on an American Heart Association scientific statement about a common, but often-undiagnosed, condition that can lead to heart disease.

OHSU becomes the first health system in Oregon to offer focused ultrasound to immediately relieve symptoms of essential tremor, tremor-dominant Parkinson’s disease. “Patients love it, and the results are instantaneous,” says Ahmed M. Raslan, M.D., FAANS.

U.S. News & World Report publishes their annual "Best Grad School" rankings; in addition to many rankings for specific specialty areas, OHSU's medical school is ranked fourth in best medical schools for primary care and 32nd in best medical schools for research.

Peter Graven, Ph.D., says relatively high vaccination rates coupled with people’s natural immunity to the virus will likely keep cases from skyrocketing again.

New research led by Fikadu Tafesse, Ph.D., finds a breakthrough infection or a booster dose provide roughly equally enhanced immune response against the virus that causes COVID-19.

Peter Graven, Ph.D., says relatively high vaccination rates coupled with people’s natural immunity to the virus will likely keep cases from skyrocketing again.

Bita Moghaddam, Ph.D., says that while studies on ketamine thus far have been limited, ketamine's use in conjunction with psychotherapy has shown some long-term positive results in treating mental health issues.

In an article featuring the rise of depression, self-harm and suicide rates among adolescents, Bonnie Nagel, Ph.D., discusses the increasing rates of loneliness: "They’re hanging out with friends, but no friends are there. It’s not the same social connectedness we need and not the kind that prevents one from feeling lonely.”

OHSU receives nearly $287 million in NIH funding in 2021, and three of its spinoff companies -- PDX Pharmaceuticals, Najit Technologies and Aronora Inc. -- also received NIH funding.

Footwear News profiles the Air Jordan 5 sneakers designed by OHSU Doernbecher patient Michael Wilson.